How do you interpret medical products & therapies — goodwill impairments?

Any impairment is a negative signal, indicating that previous acquisitions are underperforming expectations.

How does medical products & therapies — goodwill impairments compare across companies?

Standard accounting metric for assessing the health of past M&A activity.

Baxter International BAX Medical Products & Therapies — Goodwill impairments

Discontinued — last reported Q4 '25

Similar metrics at other companies

GTLSBiomedical — Goodwill Impairment

$32.81M—

GTLSBiomedical — Goodwill And Intangible Asset Impairment

$35.58M—

HASConsumer Products — Goodwill, Impairment Loss

$1.02B—

EMNAdvanced Materials — Goodwill, Impairment Loss

$0—

LDOSHealth — Goodwill impairment charges

$0—

ITOther — Goodwill impairment

$37.5M—

Other financials

Income statement

See full

Revenue$2.7B+2.9%

Gross profit$891.0M+3.5%

Operating income$66.0M+13.8%

Net income-$15.0M-112%

EPS (diluted)-$0.03-112%

Balance sheet

See full

Cash & equivalents$2.0B-12.1%

Total debt$224.0M-8.9%

Total equity$6.0B-14.7%

Total assets$19.8B-6.8%

Cash flow

See full

Operating cash flow$213.0M+210%

CapEx$128.3M+15.0%

Free cash flow$83.0M-42.1%

Valuation

See full

Market cap$10.27B-50.6%

Enterprise value$8.48B-55.6%

P/S0.9×-1.0×

Profitability

See full

Gross margin30.1%-5.9pp

Operating margin-2.7%—

Net margin-9.7%+62.5pp

FCF margin3%-2.4pp

Returns & leverage

See full

Return on equity-16.7%-76.7pp

Debt / equity0×0.0×

Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairmentLoss.

The official record: Baxter International’s 10-K, filed February 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Baxter International's medical products & therapies — goodwill impairments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Baxter International's medical products & therapies — goodwill impairments?: Baxter International (BAX) reported medical products & therapies — goodwill impairments of $0 in Q4 2025.
What does medical products & therapies — goodwill impairments mean?: A write-down of the value of acquired assets due to a decline in their expected future performance.
How do you interpret medical products & therapies — goodwill impairments?: Any impairment is a negative signal, indicating that previous acquisitions are underperforming expectations.
How does medical products & therapies — goodwill impairments compare across companies?: Standard accounting metric for assessing the health of past M&A activity.